Home Page ::: Letters in Drug Design & Discovery

ISSN: 1875-628X (Online)
ISSN: 1570-1808 (Print)


Volume 14, 12 Issues, 2017


Download PDF Flyer

http://www.lettersindrugdesigndiscovery.com/


Letters in Drug Design & Discovery

This journal supports open access

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:

G. Perry


University of Texas
San Antonio, TX
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 0.974
5 - Year: 2.25
Browse Contents
Select Volume:


Select Issue:


Select Article:


Abstracted/Indexed in




Endorsement(s)

"Letters in Drug Design & Discovery should be available in every library in the pharmaceutical industry and in universities."

R. F. Borne, Associate Director
Laboratory for Applied Drug Design and Synthesis, The University of Mississippi, USA

Forthcoming Special Issue(s)

Opportunities and challenges in anticandidal drug discovery and development


Guest Editor(s): Mohammad Abid
Tentative Publication Date: July, 2017
Submit Abstract via Email Download Description
Authors' Comments
I would like to inform you that I am happy with the quality of your services. Hope to publish more in your journal.

Dr. Bahareh Honarparvar
(School of Pharmacy and Pharmacology, University of KwaZulu-Natal, Private Bag X54001, Durban, 4000, South Africa)

Has contributed: Imidazole-based derivatives as the potential anti-platelet inhibitors: DFT and molecular docking study

Letters in Drug Design & Discovery

,

Volume 14

-

Number 5



Advertisement
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals




Related eBooks



Webmaster Contact: info@benthamscience.org Copyright © 2017 Bentham Science